{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2024-02-20T22%3A05%3A53.450Z&min-ddpModified.=2020-09-18T18%3A15%3A17.342Z&hansardHeading=Pharmacy%3A+Standards", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-ddpModified.=2024-02-20T22%3A05%3A53.450Z&min-ddpModified.=2020-09-18T18%3A15%3A17.342Z&hansardHeading=Pharmacy%3A+Standards", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2024-02-20T22%3A05%3A53.450Z&_metadata=all&min-ddpModified.=2020-09-18T18%3A15%3A17.342Z&hansardHeading=Pharmacy%3A+Standards", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-ddpModified.=2024-02-20T22%3A05%3A53.450Z&min-ddpModified.=2020-09-18T18%3A15%3A17.342Z&hansardHeading=Pharmacy%3A+Standards", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2024-02-20T22%3A05%3A53.450Z&min-ddpModified.=2020-09-18T18%3A15%3A17.342Z&hansardHeading=Pharmacy%3A+Standards", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2024-02-20T22%3A05%3A53.450Z&min-ddpModified.=2020-09-18T18%3A15%3A17.342Z&hansardHeading=Pharmacy%3A+Standards", "items" : [{"_about" : "http://data.parliament.uk/resources/1651487", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1651487/answer", "answerText" : {"_value" : "<p><del class=\"ministerial\">The early access to medicines scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorisation when there is a clear unmet medical need.<\/del><\/p><p><del class=\"ministerial\">Under the scheme, the Medicines and Healthcare products Regulatory Agency (MHRA) will give a scientific opinion on the benefit/risk balance of the medicine, based on the data available when the EAMS submission was made and the EAMS criteria. The MHRA will make an evaluation of products, including drugs such as for brain tumour treatments, once an application is received.<\/del><\/p><p><del class=\"ministerial\">If we do receive an application, it is only made public where an EAMS Scientific Opinion (SO) is awarded. All EAMS SOs are published on the EAMS webpage. All drugs that have previously held an EAMS SO are also published on the EAMS webpage.<\/del><\/p><p><ins class=\"ministerial\">The Pharmacy Access Scheme provides additional funding to pharmacies where the next nearest pharmacy is more than a 20-minute walk away. This is calculated as a 0.8-mile walking distance in areas of high deprivation and 1 mile in other areas. In 2021, we agreed updated eligibility criteria and an updated payment model with Community Pharmacy England. To be eligible for the payment, pharmacies must deliver the Community Pharmacist Consultation Service. Quality and opening hours are not included in the eligibility criteria.<\/ins><\/p><p> <\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-07-19", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1651487/answer/previousversion/88780", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
          }
          , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        }
        , "questionFirstAnswered" : [{"_value" : "2023-07-19T15:05:50.113Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2023-07-20T15:18:01.373Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-07-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pharmacy: Standards"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what assessment they have made of the level of support available under the Pharmacy Access Scheme; and whether the criteria includes the (1) quality, (2) opening hours, and (3) range of provision, of existing pharmacies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL9200"}
    , {"_about" : "http://data.parliament.uk/resources/1606159", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1606159/answer", "answerText" : {"_value" : "<p>No specific assessment has been made. However, the Department closely monitors the market. In England, access to National Health Service pharmaceutical services remains good with a similar number of community pharmacies as a decade ago and 80% of the population living within 20 minutes walking distance of a community pharmacy.<\/p><p> <\/p><p>The Pharmacy Access Scheme supports patient access and provision in areas where there are fewer community pharmacies by providing additional funding to those pharmacies. The Community Pharmacy Contractual Framework 2019-24 five-year deal committed £2.592 billion per year to the sector and outlined a joint vision for how community pharmacy would become more integrated into the NHS, deliver more clinical services, and become the first port of call for minor illnesses<strong>. <\/strong>The Government continues to implement this deal and has invested a further £100 million across 2022/23 and 2023/24 to support community pharmacies.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-03-30", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL6719"}
        , {"_value" : "HL6720"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-03-30T10:37:11.173Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-03-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pharmacy: Standards"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what assessment they have made of the impact of (1) reduced pharmacy opening hours, (2) over-capacity pharmacy services, and (3) pharmacists\u2019 staff shortages, on (a) GP, and (b) A&amp;E, services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4157", "label" : {"_value" : "Biography information for Baroness Wheeler"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Wheeler"}
      ], "uin" : "HL6718"}
    , {"_about" : "http://data.parliament.uk/resources/1606160", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1606160/answer", "answerText" : {"_value" : "<p>No specific assessment has been made. However, the Department closely monitors the market. In England, access to National Health Service pharmaceutical services remains good with a similar number of community pharmacies as a decade ago and 80% of the population living within 20 minutes walking distance of a community pharmacy.<\/p><p> <\/p><p>The Pharmacy Access Scheme supports patient access and provision in areas where there are fewer community pharmacies by providing additional funding to those pharmacies. The Community Pharmacy Contractual Framework 2019-24 five-year deal committed £2.592 billion per year to the sector and outlined a joint vision for how community pharmacy would become more integrated into the NHS, deliver more clinical services, and become the first port of call for minor illnesses<strong>. <\/strong>The Government continues to implement this deal and has invested a further £100 million across 2022/23 and 2023/24 to support community pharmacies.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-03-30", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "HL6718"}
        , {"_value" : "HL6720"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-03-30T10:37:11.22Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-03-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pharmacy: Standards"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what steps they are taking (1) to build and expand essential community pharmacy services, and (2) to prevent further closures of both large and small high street pharmacies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4157", "label" : {"_value" : "Biography information for Baroness Wheeler"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Wheeler"}
      ], "uin" : "HL6719"}
    , {"_about" : "http://data.parliament.uk/resources/1606162", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1606162/answer", "answerText" : {"_value" : "<p>Compliance support services, for example the dispensing of medicines in blister medication packs, are not nationally commissioned and therefore no data is available on how many compliance aids are assembled every year in England. Under the Equality Act 2010, pharmacies must make reasonable adjustments to their services to help patients covered by the Act which could include compliance aids where appropriate.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-03-30", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "HL6722"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-03-30T10:36:05.913Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-03-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pharmacy: Standards"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what steps they are taking to ensure that there is an adequate supply of essential services provided by pharmacies, particularly the assembly of blister medication packs to support the safe administration of medicines at home by patients, care workers and unpaid carers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4157", "label" : {"_value" : "Biography information for Baroness Wheeler"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Wheeler"}
      ], "uin" : "HL6721"}
    , {"_about" : "http://data.parliament.uk/resources/1541670", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1541670/answer", "answerText" : {"_value" : "<p>The production of aseptically compounded medicines for the National Health Service in England is approximately equal between NHS and commercial suppliers. In 2019/20, approximately 4.5 million doses of compounded medicines were prepared in NHS facilities in England. However, information on the total capacity is not held centrally.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
        }
        , "answeringMemberConstituency" : {"_value" : "Colchester"}
        , "answeringMemberPrinted" : {"_value" : "Will Quince"}
        , "dateOfAnswer" : {"_value" : "2022-11-21", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-11-21T16:24:10.217Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-11-11", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pharmacy: Standards"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the level of (a) production and (b) capacity is of aseptic services in England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4866", "label" : {"_value" : "Biography information for Alexander Stafford"}
      }
      , "tablingMemberConstituency" : {"_value" : "Rother Valley"}
      , "tablingMemberPrinted" : [{"_value" : "Alexander Stafford"}
      ], "uin" : "85061"}
    , {"_about" : "http://data.parliament.uk/resources/1491184", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1491184/answer", "answerText" : {"_value" : "<p>The Pharmacy (Preparation and Dispensing Errors \u2013 Registered Pharmacies) Order 2018 was amended to enable pharmacists to access defences against prosecution following an inadvertent dispensing error. The defences were drafted to incentivise the reporting of errors to enable learning. A survey by the Community Pharmacy Patients Safety Group found that following the amendment, 95% of pharmacists stated that errors were now reported to improve practice.<\/p><p>In 2022, these defences will be extended to pharmacists working outside a registered premises. It is expected that this will lead to further reporting of dispensing errors and provide greater learning opportunities which will increase patient and consumer safety in registered premises and other pharmacy services.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3992", "label" : {"_value" : "Biography information for James Morris"}
        }
        , "answeringMemberConstituency" : {"_value" : "Halesowen and Rowley Regis"}
        , "answeringMemberPrinted" : {"_value" : "James Morris"}
        , "dateOfAnswer" : {"_value" : "2022-09-05", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2022-09-05T11:54:41.51Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2022-07-20", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pharmacy: Standards"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce dispensing errors in community pharmacies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4822", "label" : {"_value" : "Biography information for Feryal Clark"}
      }
      , "tablingMemberConstituency" : {"_value" : "Enfield North"}
      , "tablingMemberPrinted" : [{"_value" : "Feryal Clark"}
      ], "uin" : "40981"}
    , {"_about" : "http://data.parliament.uk/resources/1303564", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1303564/answer", "answerText" : {"_value" : "<p>Discussions are ongoing with the Pharmaceutical Services Negotiating Committee (PSNC) about additional funding for costs incurred during the COVID-19 pandemic. As part of its assessment of COVID-19 costs incurred by the sector the Government will take account of the £370 million increased advance payments paid to community pharmacies<\/p><p><br> The support package for community pharmacy also included general COVID-19 business financial support, funding for Bank Holiday openings, social distancing measures and the medicine delivery service to shielded patients and free personal protective equipment, as well as non-monetary support, including the removal of some administrative tasks, flexibility in opening hours and the delayed introduction of new services. The Community Pharmacy Contractual Framework 2019-24 five-year deal was agreed with the PSNC in 2019. Negotiations on year three 2021/22 with the PSNC will begin shortly, which will take account of the effect of the COVID-19 pandemic on community pharmacy.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4380", "label" : {"_value" : "Biography information for Jo Churchill"}
        }
        , "answeringMemberConstituency" : {"_value" : "Bury St Edmunds"}
        , "answeringMemberPrinted" : {"_value" : "Jo Churchill"}
        , "dateOfAnswer" : {"_value" : "2021-03-23", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "170629"}
        , {"_value" : "170631"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-03-23T12:40:44.927Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-03-17", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pharmacy: Standards"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of whether the performance of community pharmacy during the covid-19 outbreak necessitates the creation of a new national pharmacy contract.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4079", "label" : {"_value" : "Biography information for Julian Sturdy"}
      }
      , "tablingMemberConstituency" : {"_value" : "York Outer"}
      , "tablingMemberPrinted" : [{"_value" : "Julian Sturdy"}
      ], "uin" : "170630"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 7, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}